OpenURL Connection Search

Select item for more details and to access through your institution.

Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS‐CoV‐2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL
Published in:
American Journal of Hematology, 2024, v. 99, n. 4, p. 745, doi. 10.1002/ajh.27218
By:
- Campanella, A.;
- Capasso, A.;
- Heltai, S.;
- Taccetti, C.;
- Albi, E.;
- Herishanu, Y.;
- Haggenburg, S.;
- Chatzikonstantinou, T.;
- Doubek, M.;
- Kättström, M.;
- Giannopoulos, K.;
- Simkovic, M.;
- Moreno, C.;
- Massaia, M.;
- Bumbea, H.;
- Alshemmari, S.;
- Ranghetti, P.;
- Perotta, E.;
- Martini, F.;
- Sant'Antonio, E.
Publication type:
Article
Prevence a léčba kardiovaskulárních a krvácivých komplikací u nemocných s chronickou lymfocytární leukemií léčených inhibitory Brutonovy kinázy.
Published in:
Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2023, v. 29, n. 3, p. 177
By:
- Panovská, A.;
- Arpáš, T.;
- Šimkovič, M.;
- Špaček, M.;
- Papajík, T.;
- Lysák, D.;
- Bezděková, L.;
- Doubek, M.
Publication type:
Article
Změny v imunitním systému u neléčených nemocných s chronickou lymfocytární leukémií - část 2: nespecifická imunita.
Published in:
Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2021, v. 27, n. 3, p. 218, doi. 10.48095/cctahd2021218
By:
- Vodárek, P.;
- Smolej, L.;
- Belada, D.;
- Šimkovič, M.;
- Écsiová, D.;
- Žák, P.
Publication type:
Article
Změny v imunitním systému u neléčených nemocných s chronickou lymfocytární leukemií - část 1: specifická imunita.
Published in:
Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2021, v. 27, n. 2, p. 128, doi. 10.48095/cctahd2021128
By:
- Vodárek, P.;
- Smolej, L.;
- Belada, D.;
- Šimkovič, M.;
- Écsiová, D.;
- Žák, P.
Publication type:
Article
Doporučení pro diagnostiku a léčbu chronické lymfocytární leukemie 2021.
Published in:
Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2021, v. 27, n. 1, p. 91
By:
- Smolej, L.;
- Špaček, M.;
- Pospíšilová, Š.;
- Jarošová, M.;
- Papajík, T.;
- Urbanová, R.;
- Šimkovič, M.;
- Lysák, D.;
- Brejcha, M.;
- Doubek, M.
Publication type:
Article
Rozvoj Richterovy transformace u nemocného s refrakterní chronickou lymfocytární leukemií na léčbě ibrutinibem.
Published in:
Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2020, v. 26, n. 1, p. 56
By:
- Smolej, L.;
- Šimkovič, M.;
- Zavřelová, A.;
- Kašparová, P.;
- Hoffmann, P.;
- Dvořák, P.;
- Slanina, M.;
- Krčálová, E.;
- Belada, D.;
- Žák, P.
Publication type:
Article
Doporučení pro diagnostiku a léčbu chronické lymfocytární leukemie (CLL) - 2018.
Published in:
Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2018, v. 24, n. 3, p. 208
By:
- Doubek, M.;
- Špaček, M.;
- Pospíšilová, Š.;
- Jarošová, M.;
- Papajík, T.;
- Urbanová, R.;
- Šimkovič, M.;
- Lysák, D.;
- Brejcha, M.;
- Smolej, L.
Publication type:
Article
Chloride transport in the vegetative mycelia of filamentous fungus Trichoderma viride.
Published in:
Journal of Basic Microbiology, 2004, v. 44, n. 2, p. 122
By:
- M. Šimkovič;
- R. Pokorný;
- D. Hudecová;
- Ľ. Varečka
Publication type:
Article
Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies.
Published in:
Journal of Immunology Research, 2017, p. 1, doi. 10.1155/2017/7304658
By:
- Kralickova, P.;
- Kuhnova, J.;
- Soucek, O.;
- Vodarek, P.;
- Zak, P.;
- Simkovic, M.;
- Motyckova, M.;
- Smolej, L.;
- Mala, E.;
- Andrys, C.;
- Krejsek, J.;
- Thon, V.
Publication type:
Article
FOXO1‐RICTOR AXIS INDUCES AKT PHOSPHORYLATION DURING CLL CELL ADAPTATION TO BCR INHIBITORS: IMPLICATIONS FOR COMBINATORIAL THERAPY.
Published in:
Hematological Oncology, 2023, v. 41, p. 54, doi. 10.1002/hon.3163_23
By:
- Ondrisova, L.;
- Seda, V.;
- Hoferkova, E.;
- Chiodin, G.;
- Hlavac, K.;
- Kostalova, L.;
- Pavlasova, G. Mladonicka;
- Filip, D.;
- Zeni, P. Faria;
- Oppelt, J.;
- Panovska, A.;
- Plevova, K.;
- Pospisilova, S.;
- Simkovic, M.;
- Vrbacky, F.;
- Lysak, D.;
- Fernandes, S. M.;
- Davids, M. S.;
- Maiques‐Diaz, A.;
- Charalampopoulou, S.
Publication type:
Article
ZANUBRUTINIB (ZANU) VERSUS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT‐NAïVE (TN) CLL/SLL: EXTENDED FOLLOW‐UP OF THE SEQUOIA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 235, doi. 10.1002/hon.3163_154
By:
- Shadman, M.;
- Munir, T.;
- Roback, T.;
- Brown, J. R.;
- Kahl, B. S.;
- Ghia, P.;
- Giannopoulos, K.;
- Šimkovič, M.;
- Österborg, A.;
- Laurenti, L.;
- Walker, P.;
- Opat, S.;
- Ciepluch, H.;
- Greil, R.;
- Hanna, M.;
- Tani, M.;
- Trněný, M.;
- Brander, D.;
- Flinn, I. W.;
- Grosicki, S.
Publication type:
Article
Acalabrutinib vs Rituximab Plus Idelalisib (IdR) or Bendamustine (BR) by Investigator Choice in Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia: Phase 3 ASCEND Study.
Published in:
Hematological Oncology, 2019, v. 37, p. 86, doi. 10.1002/hon.54_2629
By:
- Ghia, P.;
- Pluta, A.;
- Wach, M.;
- Lysak, D.;
- Kozak, T.;
- Simkovic, M.;
- Kaplan, P.;
- Kraychok, I.;
- Illes, A.;
- De La Serna, J.;
- Dolan, S.;
- Campbell, P.;
- Musuraca, G.;
- Jacob, A.;
- Avery, E.J.;
- Lee, J.H.;
- Chen, T.;
- Liang, W.;
- Patel, P.;
- Jurczak, W.
Publication type:
Article
IBRUTINIB DECREASES OBINUTUZUMAB‐INDUCED SECRETION OF CYTOKINES ASSOCIATED WITH INFUSION‐RELATED REACTIONS IN PATIENTS WITH CLL: ANALYSIS FROM THE ILLUMINATE STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 210, doi. 10.1002/hon.27_2630
By:
- Greil, R.;
- Tedeschi, A.;
- Moreno, C.;
- Anz, B.;
- Larratt, L.;
- Simkovic, M.;
- Gill, D.;
- Gribben, J.G.;
- Flinn, I.W.;
- Wang, Z.;
- Cheung, L.W.;
- Nguyen, A.N.;
- Zhou, C.;
- Styles, L.;
- Demirkan, F.
Publication type:
Article
DA‐EPOCH‐R VERSUS R‐CHOP IN HIGH RISK DLBCL PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP (CLSG).
Published in:
Hematological Oncology, 2019, v. 37, p. 433, doi. 10.1002/hon.107_2631
By:
- Šimkovič, M.;
- Móciková, H.;
- Ďuraš, J.;
- Kamarádová, K.;
- Štěpánková, P.;
- Janíková, A.;
- Michalka, J.;
- Žák, P.;
- Belada, D.;
- Trněný, M.
Publication type:
Article
Acalabrutinib vs Rituximab Plus Idelalisib (IdR) or Bendamustine (BR) by Investigator Choice in Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia: Phase 3 ASCEND Study.
Published in:
Hematological Oncology, 2019, v. 37, p. 86, doi. 10.1002/hon.54_2629
By:
- Ghia, P.;
- Pluta, A.;
- Wach, M.;
- Lysak, D.;
- Kozak, T.;
- Simkovic, M.;
- Kaplan, P.;
- Kraychok, I.;
- Illes, A.;
- De La Serna, J.;
- Dolan, S.;
- Campbell, P.;
- Musuraca, G.;
- Jacob, A.;
- Avery, E.J.;
- Lee, J.H.;
- Chen, T.;
- Liang, W.;
- Patel, P.;
- Jurczak, W.
Publication type:
Article
IBRUTINIB DECREASES OBINUTUZUMAB‐INDUCED SECRETION OF CYTOKINES ASSOCIATED WITH INFUSION‐RELATED REACTIONS IN PATIENTS WITH CLL: ANALYSIS FROM THE ILLUMINATE STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 210, doi. 10.1002/hon.27_2630
By:
- Greil, R.;
- Tedeschi, A.;
- Moreno, C.;
- Anz, B.;
- Larratt, L.;
- Simkovic, M.;
- Gill, D.;
- Gribben, J.G.;
- Flinn, I.W.;
- Wang, Z.;
- Cheung, L.W.;
- Nguyen, A.N.;
- Zhou, C.;
- Styles, L.;
- Demirkan, F.
Publication type:
Article
DA‐EPOCH‐R VERSUS R‐CHOP IN HIGH RISK DLBCL PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP (CLSG).
Published in:
Hematological Oncology, 2019, v. 37, p. 433, doi. 10.1002/hon.107_2631
By:
- Šimkovič, M.;
- Móciková, H.;
- Ďuraš, J.;
- Kamarádová, K.;
- Štěpánková, P.;
- Janíková, A.;
- Michalka, J.;
- Žák, P.;
- Belada, D.;
- Trněný, M.
Publication type:
Article
MAINTENANCE RITUXIMAB IMPROVES SURVIVAL IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP.
Published in:
Hematological Oncology, 2017, v. 35, p. 205, doi. 10.1002/hon.2438_69
By:
- Obr, A.;
- Klener, P.;
- Belada, D.;
- Pytlik, R.;
- Simkovic, M.;
- Salek, D.;
- Mocikova, H.;
- Prochazka, V.;
- Janikova, A.;
- Markova, J.;
- Campr, V.;
- Kodet, R.;
- Trneny, M.
Publication type:
Article
R-CHOP/R-HDAC AND RITUXIMAB MAINTENANCE RESULTS IN HIGH COMPLETE REMISSION RATE, MINIMAL RESIDUAL DISEASE NEGATIVITY, AND EXCELLENT SURVIVAL IN ELDERLY MCL PATIENTS.
Published in:
Hematological Oncology, 2017, v. 35, p. 204, doi. 10.1002/hon.2438_68
By:
- Klener, P.;
- Fronkova, E.;
- Belada, D.;
- Forsterova, K.;
- Pytlik, R.;
- Kalinova, M.;
- Simkovic, M.;
- Salek, D.;
- Mocikova, H.;
- Prochazka, V.;
- Blahovcová, P.;
- Janikova, A.;
- Markova, J.;
- Obr, A.;
- Berkova, A.;
- Vaskova, M.;
- Mejstrikova, E.;
- Campr, V.;
- Kubinyi, J.;
- Jaksa, R.
Publication type:
Article
Burkitt lymphoma-multicenter retrospective data analysis from the Czech Lymphoma Study Group- NiHiL project.
Published in:
Hematological Oncology, 2017, v. 35, p. 342, doi. 10.1002/hon.2439_90
By:
- Sýkorová, A.;
- Pytlík, R.;
- Móciková, H.;
- Janíková, A.;
- Procházka, V.;
- Belada, D.;
- Šálek, D.;
- Benešová, K.;
- Klener, P.;
- Ďuraš, J.;
- Smolej, L.;
- Šimkovič, M.;
- Campr, V.;
- Vosáhlová, V.;
- Blahovcová, P.;
- Trněný, M.
Publication type:
Article
Differences in gut microbiota activity (antimicrobials, potential mutagens, and sterols) according to diet.
Published in:
Acta Alimentaria, 2017, v. 46, n. 1, p. 61, doi. 10.1556/066.2017.46.1.8
By:
- Olejníková, P.;
- Kaszonyi, A.;
- Šimkovič, M.;
- Lakatoš, B.;
- Kaliňák, M.;
- Valachovičová, M.;
- Birošová, L.
Publication type:
Article
Developmental changes in the<sup>45</sup>Ca<sup>2+</sup> uptake by Trichoderma viride mycelium.
Published in:
Folia Microbiologica, 1997, v. 42, n. 2, p. 125, doi. 10.1007/BF02898720
By:
- Šimkovič, M.;
- Ortega-Perez, R.;
- Turian, G.;
- Betina, V.;
- Hudecová, D.;
- Varečka, L’.
Publication type:
Article
Hodnocení vybraných ukazatelů apoptózy a angiogeneze u chronické lymfocytární leukemie.
Published in:
Internal Medicine / Vnitrni Lekarstvi, 2013, v. 59, n. 9, p. 782
By:
- Motyčková, M.;
- Smolej, L.;
- Andrýs, C.;
- Řezáčová, V.;
- Šimkovič, M.;
- Belada, D.;
- Žák, P.
Publication type:
Article

Found: 23